Implantable Medical Device Code Path Metrics - EP4642528A1

The EPO published international patent application EP4642528A1 titled 'Implantable Medical Device (IMD) With Code Path Metrics' on April 8, 2026. The application covers systems and methods for an implantable neuromodulation device that captures and analyzes code path execution metrics during device operation, with classifications spanning electrical therapy (A61N 1/36), machine learning (G06N 20/00), and health informatics (G16H 40/67, G16H 50/20, G16H 50/70).

Medical device manufacturers developing neuromodulation or implantable therapeutic systems should monitor this published application to assess potential freedom-to-operate implications in EU markets. The publication puts competitors on notice of the applicant's claimed technical approach combining code instrumentation with machine learning analysis in implantable device contexts.